國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Bioprospectingsuccess, potential and...

Lima, Nelson.

Bioprospectingsuccess, potential and constraints /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Bioprospectingedited by Russell Paterson, Nelson Lima.
其他題名:	success, potential and constraints /
其他作者:	Paterson, Russell.
出版者:	Cham :Springer International Publishing :2017.
面頁冊數:	x, 303 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Microbial biotechnology.
電子資源:	http://dx.doi.org/10.1007/978-3-319-47935-4
ISBN:	9783319479354$q(electronic bk.)

Bioprospectingsuccess, potential and constraints /
Bioprospectingsuccess, potential and constraints /[electronic resource] :edited by Russell Paterson, Nelson Lima. - Cham :Springer International Publishing :2017. - x, 303 p. :ill., digital ;24 cm. - Topics in biodiversity and conservation,v.161875-1288 ;. - Topics in biodiversity and conservation ;v.14..

Forward -- 1. Bioprospecting: An Industrial Perspective -- 2. Current Status and Perspectives in Marine Biodiscovery -- 3. Contributions of microbial resource centers to bioprospecting of bacteria and filamentous microfungi -- 4. Bioprospecting Archaea: focus on extreme halophiles -- 5. Bioprospecting soil metagenomes for antibiotics -- 6. Biotechnological applications of the Roseobacter clade -- 7. Iwokrama fungal/plant bioprospecting project 2000-2003 - a model for the future?- 8. Bioprospecting with Brazilian fungi -- 9. Secondary metabolites of mine waste acidophilic fungi -- 10. Insect bioprospecting especially in India -- 11. Phages against infectious diseases -- 12. The role of biodiversity centres in bioprospecting: a case study from Sarawak -- 13. Legal and ethnoecological components of bioprospecting -- 14. Bioprospecting insights.

This book considers all aspects of bioprospecting in 14 succinct chapters and a forward by David Hawksworth. The organisms addressed include plants, insects, fungi, bacteria and phages. Bioprospecting has never been more relevant and is of renewed interest, because of the extremely worrying rise in novel, resistant pathogenic microorganisms. The practices in pharmaceutical companies have failed to deliver novel antibiotics to control these infections. We need to look for new sources of drugs from the environment on a massive scale as drug discovery is "too important to fail". Furthermore, the field can add great value to ecosystems in terms of economics, while providing additional reasons for maintaining associated services, such as food provision, benign climate, effective nutrient cycling and cultural practices. Bioprospecting provides another reason why climate change must be reduced in order to preserve relevant environments. Previous bioprospecting projects should be re-visited and established biodiversity centres have a major role. Many different ecosystems exist which contain unique organisms with the potential to supply novel antibiotics, enzymes, food, and cosmetics, or they may simply have aesthetic value. The book stresses the difficulties in obtaining successful products and yet describes why natural products should be investigated over combinatorial chemistry. Personal experience of bioprospecting projects are given significance. Issues such as how to share the benefits equitably with local communities are described and why pharmaceutical companies can be reluctant to be involved. Legal issues are discussed. Finally, there has never been a better time for a new book on bioprospecting, because of the need to preserve ecosystems, and from the emergence of resistant pathogenic microorganisms.

ISBN: 9783319479354$q(electronic bk.)

Standard No.: 10.1007/978-3-319-47935-4doiSubjects--Topical Terms:

188971
Microbial biotechnology.

LC Class. No.: TP248.27.M53

Dewey Class. No.: 660.62

Bioprospectingsuccess, potential and constraints /
LDR:03727nmm a2200325 a 4500 001 506061
003 DE-He213
005 20161212064335.0
006 m d
007 cr nn 008maaau
008 171030s2017 gw s 0 eng d
020 $a 9783319479354$q(electronic bk.)
020 $a 9783319479330$q(paper)
024 7 $a 10.1007/978-3-319-47935-4 $2 doi
035 $a 978-3-319-47935-4
040 $a GP $c GP
041 0 $a eng
050 4 $a TP248.27.M53
072 7 $a RNCB $2 bicssc
072 7 $a SCI020000 $2 bisacsh
082 0 4 $a 660.62 $2 23
090 $a TP248.27.M53 $b B615 2017
245 0 0 $a Bioprospecting $h [electronic resource] : $b success, potential and constraints / $c edited by Russell Paterson, Nelson Lima.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2017.
300 $a x, 303 p. : $b ill., digital ; $c 24 cm.
490 1 $a Topics in biodiversity and conservation, $x 1875-1288 ; $v v.16
505 0 $a Forward -- 1. Bioprospecting: An Industrial Perspective -- 2. Current Status and Perspectives in Marine Biodiscovery -- 3. Contributions of microbial resource centers to bioprospecting of bacteria and filamentous microfungi -- 4. Bioprospecting Archaea: focus on extreme halophiles -- 5. Bioprospecting soil metagenomes for antibiotics -- 6. Biotechnological applications of the Roseobacter clade -- 7. Iwokrama fungal/plant bioprospecting project 2000-2003 - a model for the future?- 8. Bioprospecting with Brazilian fungi -- 9. Secondary metabolites of mine waste acidophilic fungi -- 10. Insect bioprospecting especially in India -- 11. Phages against infectious diseases -- 12. The role of biodiversity centres in bioprospecting: a case study from Sarawak -- 13. Legal and ethnoecological components of bioprospecting -- 14. Bioprospecting insights.
520 $a This book considers all aspects of bioprospecting in 14 succinct chapters and a forward by David Hawksworth. The organisms addressed include plants, insects, fungi, bacteria and phages. Bioprospecting has never been more relevant and is of renewed interest, because of the extremely worrying rise in novel, resistant pathogenic microorganisms. The practices in pharmaceutical companies have failed to deliver novel antibiotics to control these infections. We need to look for new sources of drugs from the environment on a massive scale as drug discovery is "too important to fail". Furthermore, the field can add great value to ecosystems in terms of economics, while providing additional reasons for maintaining associated services, such as food provision, benign climate, effective nutrient cycling and cultural practices. Bioprospecting provides another reason why climate change must be reduced in order to preserve relevant environments. Previous bioprospecting projects should be re-visited and established biodiversity centres have a major role. Many different ecosystems exist which contain unique organisms with the potential to supply novel antibiotics, enzymes, food, and cosmetics, or they may simply have aesthetic value. The book stresses the difficulties in obtaining successful products and yet describes why natural products should be investigated over combinatorial chemistry. Personal experience of bioprospecting projects are given significance. Issues such as how to share the benefits equitably with local communities are described and why pharmaceutical companies can be reluctant to be involved. Legal issues are discussed. Finally, there has never been a better time for a new book on bioprospecting, because of the need to preserve ecosystems, and from the emergence of resistant pathogenic microorganisms.
650 0 $a Microbial biotechnology. $3 188971
650 0 $a Medicinal plants $x Biotechnology. $3 251832
650 0 $a Biodiversity. $3 273941
650 1 4 $a Life Sciences. $3 273679
650 2 4 $a Environmental Law/Policy/Ecojustice. $3 274783
650 2 4 $a Sustainable Development. $3 277403
650 2 4 $a Biotechnology. $3 188829
700 1 $a Paterson, Russell. $3 771828
700 1 $a Lima, Nelson. $3 771829
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Topics in biodiversity and conservation ; $v v.14. $3 740488
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-47935-4
950 $a Biomedical and Life Sciences (Springer-11642)